Charles Schwab’s ICU Medical ICUI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $48.5M | Buy |
331,052
+8,573
| +3% | +$1.12M | 0.01% | 1269 |
|
|
2026
Q1 | $41.6M | Buy |
322,479
+12,850
| +4% | +$1.85M | 0.01% | 1275 |
|
|
2025
Q4 | $44.2M | Buy |
309,629
+2,397
| +0.8% | +$321K | 0.01% | 1237 |
|
|
2025
Q3 | $36.9M | Buy |
307,232
+735
| +0.2% | +$93.1K | 0.01% | 1350 |
|
|
2025
Q2 | $40.5M | Buy |
306,497
+8,672
| +3% | +$1.18M | 0.01% | 1234 |
|
|
2025
Q1 | $41.4M | Sell |
297,825
-6,330
| -2% | -$982K | 0.01% | 1198 |
|
|
2024
Q4 | $47.2M | Buy |
304,155
+3,048
| +1% | +$516K | 0.01% | 1164 |
|
|
2024
Q3 | $54.9M | Buy |
301,107
+27,927
| +10% | +$4.13M | 0.01% | 1064 |
|
|
2024
Q2 | $32.4M | Buy |
273,180
+61,544
| +29% | +$6.48M | 0.01% | 1359 |
|
|
2024
Q1 | $22.7M | Buy |
211,636
+18,863
| +10% | +$1.88M | 0.01% | 1534 |
|
|
2023
Q4 | $19.2M | Buy |
192,773
+23,816
| +14% | +$2.33M | ﹤0.01% | 1625 |
|
|
2023
Q3 | $20.1M | Buy |
168,957
+11,364
| +7% | +$1.7M | 0.01% | 1509 |
|
|
2023
Q2 | $28.1M | Buy |
157,593
+1,634
| +1% | +$300K | 0.01% | 1257 |
|
|
2023
Q1 | $25.7M | Buy |
155,959
+4,907
| +3% | +$844K | 0.01% | 1278 |
|
|
2022
Q4 | $23.8M | Buy |
151,052
+7,313
| +5% | +$1.11M | 0.01% | 1314 |
|
|
2022
Q3 | $21.6M | Buy |
143,739
+8,125
| +6% | +$1.35M | 0.01% | 1309 |
|
|
2022
Q2 | $22.3M | Buy |
135,614
+3,454
| +3% | +$665K | 0.01% | 1325 |
|
|
2022
Q1 | $29.4M | Buy |
132,160
+5,063
| +4% | +$1.13M | 0.01% | 1243 |
|
|
2021
Q4 | $30.2M | Buy |
127,097
+4,064
| +3% | +$949K | 0.01% | 1263 |
|
|
2021
Q3 | $28.7M | Sell |
123,033
-36,756
| -23% | -$7.71M | 0.01% | 1265 |
|
|
2021
Q2 | $32.9M | Buy |
159,789
+7,602
| +5% | +$1.56M | 0.01% | 1179 |
|
|
2021
Q1 | $31.3M | Sell |
152,187
-1,796
| -1% | -$379K | 0.01% | 1158 |
|
|
2020
Q4 | $33M | Buy |
153,983
+3,353
| +2% | +$650K | 0.01% | 1036 |
|
|
2020
Q3 | $27.5M | Sell |
150,630
-847
| -0.6% | -$159K | 0.01% | 997 |
|
|
2020
Q2 | $27.9M | Buy |
151,477
+7,050
| +5% | +$1.4M | 0.01% | 943 |
|
|
2020
Q1 | $29.1M | Buy |
144,427
+6,766
| +5% | +$1.3M | 0.02% | 760 |
|
|
2019
Q4 | $25.8M | Buy |
137,661
+5,794
| +4% | +$997K | 0.01% | 1037 |
|
|
2019
Q3 | $21M | Buy |
131,867
+24,423
| +23% | +$4.86M | 0.01% | 1116 |
|
|
2019
Q2 | $27.1M | Buy |
107,444
+5,197
| +5% | +$1.2M | 0.02% | 937 |
|
|
2019
Q1 | $24.5M | Buy |
102,247
+7,049
| +7% | +$1.69M | 0.02% | 984 |
|
|
2018
Q4 | $21.9M | Sell |
95,198
-8,587
| -8% | -$2.12M | 0.02% | 943 |
|
|
2018
Q3 | $29.3M | Buy |
103,785
+36,286
| +54% | +$10.6M | 0.02% | 877 |
|
|
2018
Q2 | $19.8M | Sell |
67,499
-12,738
| -16% | -$3.48M | 0.01% | 1081 |
|
|
2018
Q1 | $20.3M | Buy |
80,237
+8,486
| +12% | +$1.99M | 0.02% | 994 |
|
|
2017
Q4 | $15.5M | Buy |
71,751
+4,360
| +6% | +$882K | 0.01% | 1171 |
|
|
2017
Q3 | $12.5M | Buy |
67,391
+4,873
| +8% | +$850K | 0.01% | 1251 |
|
|
2017
Q2 | $10.8M | Buy |
62,518
+470
| +0.8% | +$75.4K | 0.01% | 1300 |
|
|
2017
Q1 | $9.47M | Buy |
62,048
+4,829
| +8% | +$706K | 0.01% | 1349 |
|
|
2016
Q4 | $8.43M | Buy |
57,219
+3,890
| +7% | +$563K | 0.01% | 1384 |
|
|
2016
Q3 | $6.74M | Buy |
53,329
+4,440
| +9% | +$535K | 0.01% | 1440 |
|
|
2016
Q2 | $5.51M | Buy |
48,889
+2,004
| +4% | +$208K | 0.01% | 1500 |
|
|
2016
Q1 | $4.88M | Buy |
46,885
+834
| +2% | +$79.7K | 0.01% | 1533 |
|
|
2015
Q4 | $5.19M | Buy |
46,051
+2,927
| +7% | +$323K | 0.01% | 1495 |
|
|
2015
Q3 | $4.72M | Buy |
43,124
+2,702
| +7% | +$289K | 0.01% | 1511 |
|
|
2015
Q2 | $3.87M | Sell |
40,422
-10,372
| -20% | -$969K | 0.01% | 1716 |
|
|
2015
Q1 | $4.73M | Sell |
50,794
-11,364
| -18% | -$994K | 0.01% | 1548 |
|
|
2014
Q4 | $5.09M | Sell |
62,158
-9,206
| -13% | -$706K | 0.01% | 1430 |
|
|
2014
Q3 | $4.58M | Buy |
71,364
+2,729
| +4% | +$167K | 0.01% | 1442 |
|
|
2014
Q2 | $4.17M | Sell |
68,635
-146
| -0.2% | -$8.62K | 0.01% | 1542 |
|
|
2014
Q1 | $4.12M | Sell |
68,781
-12,971
| -16% | -$799K | 0.01% | 1486 |
|
|
2013
Q4 | $5.21M | Sell |
81,752
-28,225
| -26% | -$1.82M | 0.01% | 1226 |
|
|
2013
Q3 | $7.56M | Buy |
109,977
+1,003
| +0.9% | +$71.6K | 0.02% | 817 |
|
|
2013
Q2 | $7.98M | Buy |
+108,974
| New | +$7.21M | 0.02% | 684 |
|
Other funds holding ICUI
JT
Charles Schwab's ICUI Position: Q2 2026 in Review
Charles Schwab increased its ICU Medical (ICUI) stake by 2.7% in Q2 2026, buying an estimated $1.12M and bringing the position to 331,052 shares worth $48.5M. The position accounts for 0.01% of the portfolio, ranked #1269.
Charles Schwab first reported a position in ICUI in Q2 2013 and has held it in 53 quarters since. The position peaked at $54.9M in Q3 2024. 288 funds tracked by Wall St. Rank hold ICUI as of Q2 2026.
- Charles Schwab held 331,052 shares of ICU Medical worth $48.5M as of Q2 2026.
- Charles Schwab bought 8,573 ICU Medical shares in Q2 2026, an estimated $1.12M.
- ICU Medical made up 0.01% of Charles Schwab's portfolio in Q2 2026, its #1269 holding.
- Charles Schwab first reported a position in ICU Medical in Q2 2013 and has held it in 53 quarters since.
- Charles Schwab's ICU Medical position peaked at $54.9M in Q3 2024.
- 288 funds tracked by Wall St. Rank held ICU Medical as of Q2 2026.
Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.